We are live on !
Find out more
Rangeley Capital Portfolio holdings
AUM
$109M
Turnover
49.06%
1-Year Est. Return
97.13%
This Fund
S&P 500
This Quarter Est. Return
+34.11%
1 Year Est. Return
+97.13%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$109M
AUM Growth
+$6.53M
(+6.3%)
Cap. Flow
-$6.26M
Cap. Flow % of AUM
Cap. Flow %
-5.72%
Top 10 Holdings %
Top 10 Hldgs %
32.08%
Holding
212
New
75
Increased
28
Reduced
43
Closed
29
Avg Time Held
Equity + Options
0.4
years
Top 10 Avg Time Held
Equity + Options
0.3
years
Top 20 Avg Time Held
Equity + Options
0.4
years
Avg Time Held Equity only
0.4
years
Top 10 Avg Time Held Equity only
0.3
years
Top 20 Avg Time Held Equity only
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nomad Foods
NOMD
|
+$1.34M |
| 2 |
Mountain Lake Acquisition Corp II
MLAA
|
+$1.27M |
| 3 |
Distribution Solutions Group
DSGR
|
+$1.26M |
| 4 |
enGene Therapeutics
ENGN
|
+$1.24M |
| 5 |
Abivax
ABVX
|
+$1.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revolution Medicines
RVMD
|
+$8.47M |
| 2 |
Leggett & Platt
LEG
|
+$2.1M |
| 3 |
Icon
ICLR
|
+$1.96M |
| 4 |
Kezar Life Sciences
KZR
|
+$1.8M |
| 5 |
Mister Car Wash
MCW
|
+$1.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.11% |
| 2 | Consumer Discretionary | 14.33% |
| 3 | Financials | 12.51% |
| 4 | Miscellaneous | 10.11% |
| 5 | Real Estate | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Driven Brands
DRVN
$1.93B
| $7.22M | 6.6% |
518,246
-107,254
| -17% | -$1.41M |
2026 Q1
1 quarter
|
|
|
2
Revolution Medicines Inc Warrant
RVMDW
$97.7M
| $4.68M | 4.28% |
+25,000
| New | +$135K |
2026 Q2
0 quarters
|
|
3
Prothena Corp
PRTA
$431M
| $4.09M | 3.73% |
417,270
-32,190
| -7% | -$318K |
2025 Q2
4 quarters
|
|
4
Seaport Entertainment Group
SEG
$289M
| $4.08M | 3.73% |
153,517
| – | – |
2024 Q4
6 quarters
|
|
5
Grindr
GRND
$2.28B
| $3.16M | 2.89% |
220,000
-14,000
| -6% | -$181K |
2025 Q4
2 quarters
|
|
6
Star Holdings Shares of Beneficial Interest
STHO
$90.9M
| $2.96M | 2.71% |
324,408
+50,336
| +18% | +$435K |
2024 Q4
6 quarters
|
|
7
Full House Resorts
FLL
$31.5M
| $2.58M | 2.36% |
925,578
+10,000
| +1% | +$26.4K |
2024 Q4
6 quarters
|
|
8
Arbutus Biopharma
ABUS
$832M
| $2.4M | 2.19% |
500,000
| – | – |
2024 Q4
6 quarters
|
|
9
TripAdvisor
TRIP
$1.08B
| $2.08M | 1.9% |
152,000
-38,000
| -20% | -$430K |
2026 Q1
1 quarter
|
|
10
EchoStar
ECHO
$26B
| $1.85M | 1.69% |
17,800
-200
| -1% | -$24.4K |
2025 Q3
3 quarters
|
|
|
11
Abivax
ABVX
$7.55B
| $1.73M | 1.58% |
13,000
+9,000
| +225% | +$1.02M |
2025 Q3
3 quarters
|
|
12
Green Dot
GDOT
$691M
| $1.72M | 1.57% |
127,594
-35,138
| -22% | -$440K |
2026 Q1
1 quarter
|
|
|
13
Distribution Solutions Group
DSGR
$1.62B
| $1.72M | 1.57% |
63,000
+46,143
| +274% | +$1.26M |
2026 Q1
1 quarter
|
|
14
DELISTED
Theravance Biopharma
TBPH
| $1.69M | 1.55% |
99,500
-3,500
| -3% | -$57.9K |
2026 Q1
1 quarter
|
|
15
Rallybio
RLYB
$88.5M
| $1.68M | 1.53% |
104,850
+74,720
| +248% | +$961K |
2025 Q3
3 quarters
|
|
16
Orion Office REIT
ONL
$128M
| $1.67M | 1.53% |
578,567
-336,433
| -37% | -$921K |
2026 Q1
1 quarter
|
|
17
Monro
MNRO
$419M
| $1.65M | 1.51% |
96,500
+44,156
| +84% | +$723K |
2026 Q1
1 quarter
|
|
|
18
Revolution Medicines
RVMD
$39.4B
| $1.63M | 1.49% |
8,700
-58,000
| -87% | -$8.47M |
2026 Q1
1 quarter
|
|
19
Brighthouse Financial
BHF
$2.58B
| $1.58M | 1.45% |
25,000
| – | – |
2025 Q3
3 quarters
|
|
20
Janux Therapeutics
JANX
$1.02B
| $1.5M | 1.37% |
97,978
-24,522
| -20% | -$355K |
2025 Q4
2 quarters
|
|
|
21
Nomad Foods
NOMD
$1.66B
| $1.48M | 1.35% |
+135,000
| New | +$1.34M |
2026 Q2
0 quarters
|
|
22
Arvinas
ARVN
$478M
| $1.46M | 1.33% |
175,590
-48,400
| -22% | -$451K |
2025 Q1
5 quarters
|
|
23
Delek US
DK
$4.8B
| $1.37M | 1.25% |
27,000
-33,000
| -55% | -$1.46M |
2024 Q4
6 quarters
|
|
24
DELISTED
Warner Bros
WBD
| $1.36M | 1.24% |
51,000
| – | – |
2025 Q4
2 quarters
|
|
25
ZIM Integrated Shipping Services
ZIM
$3.56B
| $1.35M | 1.24% |
52,000
-3,000
| -5% | -$77.4K |
2025 Q4
2 quarters
|
|
Similar funds
S2L
Rangeley Capital's Q2 2026 Portfolio in Review
As of Q2 2026, Rangeley Capital held 212 positions worth $109M, up 6.3% from $103M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Rangeley Capital withdrew a net $6.26M in Q2 2026, closing 29 positions and reducing 43 holdings. Its most notable exit was Leggett & Platt, an estimated $2.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Rangeley Capital opened a new position in Nomad Foods worth $1.48M.
- Rangeley Capital's largest Q2 2026 buy was Nomad Foods: 135,000 shares worth $1.48M.
- Rangeley Capital added most to Distribution Solutions Group in Q2 2026, an estimated $1.26M increase.
- Rangeley Capital's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $8.47M.
- Rangeley Capital fully exited Leggett & Platt in Q2 2026, selling an estimated $2.1M.
- Rangeley Capital's ten largest holdings make up 32% of its $109M portfolio in Q2 2026.
- Rangeley Capital opened 75 new positions and closed 29 in Q2 2026.
- Rangeley Capital's portfolio value rose 6.3% quarter-over-quarter to $109M.
Based on Rangeley Capital's 13F filing for Q2 2026, filed 14 Aug 2026.